MTFB Motif Bio plc

9.10
+0.41  (5%)
Previous Close 8.69
Open 8.98
Price To book 9.10
Market Cap 89127775
Shares 9,794,261
Volume 18,084
Short Ratio 2.10
Av. Daily Volume 2,673

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due 4Q 2017.
Iclaprim - REVIVE-2
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 data released April 18, 2017 - primary endpoint of non-inferiority met.
Iclaprim -REVIVE-1
Acute bacterial skin and skin structure infections (ABSSSI)